FindTrial
Sign In

Effect of an enhanced recovery after surgery protocol in pancreaticoduodenectomy: A meta-analysis of randomized controlled trials

ERAS in pancreaticoduodenectomy: A meta-analysis of RCT - ERAS in pancreaticoduodenectomy: A meta-analysis of RCT

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000040133
Enrollment
700
Registered
2020-04-12
Start date
2020-04-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing pancreaticoduodenectomy

Interventions

None listed

Sponsors

Erasmus MC
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria were as follows: patients undergoing pancreaticoduodenectomy; the assessment of ERAS; and postoperative ou tcomes.

Exclusion criteria

Exclusion criteria: Records without abstracts, confer ence abstracts, case reports, retrospective studies and reviews were excluded.

Design outcomes

Primary

MeasureTime frame
The primary outcome is short-term outcomes in pancreaticoduodenectomy—

Countries

Japan,Europe

Contacts

Public ContactKosei Takagi

Erasmus MC Surgery

k.takagi@erasmusmc.nl+31643802627

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026